Marshall Wace’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-615,085
| Closed | -$1.57M | – | 2888 |
|
|
2025
Q1 | $1.57M | Buy |
615,085
+513,186
| +504% | +$1.31M | ﹤0.01% | 1478 |
|
|
2024
Q4 | $192K | Buy |
+101,899
| New | +$192K | ﹤0.01% | 2205 |
|
|
2023
Q3 | – | Sell |
-562,139
| Closed | -$1.12M | – | 2205 |
|
|
2023
Q2 | $1.12M | Buy |
562,139
+411,781
| +274% | +$824K | ﹤0.01% | 1334 |
|
|
2023
Q1 | $316K | Buy |
+150,358
| New | +$316K | ﹤0.01% | 1804 |
|